Dietary fibre as a unifying remedy for the whole spectrum of obesity-associated cardiovascular risk

Nutrients

Volumn 10, Issue 7, 2018, Pages

  Bozzetto, Lutgarda ^a   Costabile, Giuseppina ^a   Della Pepa, Giuseppe ^a   Ciciola, Paola ^a   Vetrani, Claudia ^a   Vitale, Marilena ^a   Rivellese, Angela A ^a   Annuzzi, Giovanni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Cardiovascular risk; Diabetes type 2; Dietary fibre; Dyslipidemia; Hypertension; Insulin resistance; Metabolic syndrome; Obesity

Indexed keywords

BETA GLUCAN; GUAR GUM; HYDROXYPROPYLMETHYLCELLULOSE; INTERLEUKIN 1BETA; INTERLEUKIN 6; ISPAGULA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MANNAN; PECTIN; TUMOR NECROSIS FACTOR;

BLOOD GLUCOSE MONITORING; BODY MASS; BODY WEIGHT; BODY WEIGHT LOSS; CARDIOVASCULAR RISK; DIETARY FIBER; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIPID METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ADMINISTRATION AND DOSAGE; CARDIOVASCULAR DISEASE; COMPLICATION; PHARMACOLOGY; RISK FACTOR;

CARDIOVASCULAR DISEASES; DIETARY FIBER; HUMANS; OBESITY; RISK FACTORS;

EID: 85050614708     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu10070943     Document Type: Review

References (139)

1. The GBD 2015 Obesity Collaborators. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N. Engl. J. Med. 2017, 377, 13-27.
2. Pigeyre, M.; Yazdi, F.T.; Kaur, Y.; Meyre, D. Recent progress in genetics, epigenetics and metagenomics unveils the pathophysiology of human obesity. Clin. Sci. 2016, 230, 943-986. [CrossRef] [PubMed]
3. Van der Klaauw, A.A.; Farooqi, I.S. The hunger genes: Pathways to obesity. Cell 2015, 261,119-132. [CrossRef] [PubMed]
4. Grant, R.W.; Dixit, V.D. Adipose tissue as an immunological organ. Obesity 2015, 23, 512–518. [CrossRef] [PubMed]
5. Bozzetto, L.; Prinster, A.; Mancini, M.; Giacco, R.; De Natale, C.; Salvatore, M.; Riccardi, G.; Rivellese, A.A.; Annuzzi, G. Liver fat in obesity: Role of type 2 diabetes mellitus and adipose tissue distribution. Eur. J. Clin. Investig. 2011, 41, 39–44. [CrossRef] [PubMed]
6. Costabile, G.; Annuzzi, G.; Di Marino, L.; De Natale, C.; Giacco, R.; Bozzetto, L.; Cipriano, P.; Santangelo, C.; Masella, R.; Rivellese, A.A. Fasting and post-prandial adipose tissue lipoprotein lipase and hormone-sensitive lipase in obesity and type 2 diabetes. J. Endocrinol. Investig. 2011, 34, 110–114. [CrossRef] [PubMed]
7. Tchkonia, T.; Thomou, T.; Zhu, Y.; Karagiannides, I.; Pothoulakis, C.; Jensen, M.D.; Kirkland, J.L. Mechanisms and metabolic implications of regional differences among fat depots. Cell MeTable 2013, 17, 644–656. [CrossRef] [PubMed]
8. Kaur, J. A comprehensive review on metabolic syndrome. Cardiol. Res. Pract. 2014, 2014, 943162. [CrossRef] [PubMed]
9. Neuschwander-Tetri, B.A.; Caldwell, S.H. Nonalcoholic steatohepatitis: Summary of an AASLD single topic conference. Hepatology 2003, 37, 1202–1219. [CrossRef] [PubMed]
10. Masulli, M.; Patti, L.; Riccardi, G.; Vaccaro, O.; Annuzzi, G.; Ebbesson, S.O.; Fabsitz, R.R.; Howard, W.J.; Otvos, J.D.; Roman, M.J.; et al. Relation among lipoprotein subfractions and carotid atherosclerosis in Alaskan Eskimos (from the GOCADAN Study). Am. J. Cardiol. 2009, 104, 1516–1521. [CrossRef] [PubMed]
11. McCullough, A.J. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin. Liver Dis. 2004, 8, 521–533. [CrossRef] [PubMed]
12. Annuzzi, G.; Rivellese, A.A.; Wang, H.; Patti, L.; Vaccaro, O.; Riccardi, G.; Ebbesson, S.O.; Comuzzie, A.G.; Umans, J.G.; Howard, B.V. Lipoprotein subfractions and dietary intake of n − 3 fatty acid: The Genetics of Coronary Artery Disease in Alaska Natives study. Am. J. Clin. Nutr. 2012, 95, 1315–1322. [CrossRef] [PubMed]
13. Hall, J.E.; da Silva, A.A.; do Carmo, J.M.; Dubinion, J.; Hamza, S.; Munusamy, S.; Smith, G.; Stec, D.E. Obesity-induced hypertension: Role of sympathetic nervous system, leptin, and melanocortins. J. Biol. Chem. 2010, 285, 17271–17276. [CrossRef] [PubMed]
14. DeVries, J.W. The definition of dietary fibre. Cereal Foods World 2001, 46, 112–129.
15. McRorie, J.W., Jr. Evidence-based approach to fiber supplements and clinically meaningful health benefits, part 1: What to look for and how to recommend an effective fiber therapy. Nutr. Today 2015, 50, 82–89. [CrossRef] [PubMed]
16. Apovian, C.M.; Aronne, L.J.; Bessesen, D.H.; McDonnell, M.E.; Murad, M.H.; Pagotto, U.; Ryan, D.H.; Still, C.D.; Endocrine Society. Pharmacological management of obesity: An Endocrine Society clinical practice guideline. J. Clin. Endocrinol. MeTab. 2015, 100, 342–362. [CrossRef] [PubMed]
17. Garve, W.T.; Mechanick, J.I.; Brett, E.M.; Garber, A.J.; Hurley, D.L.; Jastreboff, A.M.; Nadolsky, K.; Pessah-Pollack, R.; Plodkowski, R.; Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr. Pract. 2016, 22, S1–S203. [CrossRef] [PubMed]
18. American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Obesity Expert Panel, 2013. Expert Panel Report: Guidelines (2013) for the management of overweight and obesity in adults. Obesity 2014, 22, S41–S410.
19. Newby, P.K.; Maras, J.; Bakun, P.; Muller, D.; Ferrucci, L.; Tucker, K.L. Intake of whole grains, refined grains, and cereal fibre measured with 7-d diet records and associations with risk factors for chronic disease. Am. J. Clin. Nutr. 2007, 86, 1745–1753. [CrossRef] [PubMed]
20. McKeown, N.M.; Yoshida, M.; Shea, M.K.; Jacques, P.F.; Lichtenstein, A.H.; Rogers, G.; Booth, S.L.; Saltzman, E. Whole-Grain Intake and Cereal Fibre Are Associated with Lower Abdominal Adiposity in Older Adults. J. Nutr. 2009, 139, 1950–1955. [CrossRef] [PubMed]
21. Liu, S.; Willett, W.C.; Manson, J.E.; Hu, F.B.; Rosner, B.; Colditz, G. Relation between changes in intakes of dietary fibre and grain products and changes in weight and development of obesity among middle-aged women. Am. J. Clin. Nutr. 2003, 78, 920–927. [CrossRef] [PubMed]
22. Ludwig, D.S.; Pereira, M.A.; Kroenke, C.H.; Hilner, J.E.; Van Horn, L.; Slattery, M.L.; Jacobs, D.R. Dietary fibre, weight gain, and cardiovascular disease risk factors in young adults. JAMA 1999, 282, 1539–1546. [CrossRef] [PubMed]
23. Koh-Banerjee, P.; Franz, M.; Sampson, L.; Liu, S.; Jacobs, D.R.J.; Spiegelman, D.; Willett, W.; Rimm, E. Changes in whole-grain, bran, and cereal fibre consumption in relation to 8-yr weight gain among men. Am. J. Clin. Nutr. 2004, 80, 1237–1245. [CrossRef] [PubMed]
24. Schulz, M.; Nothlings, U.; Hoffmann, K.; Bergmann, M.M.; Boeing, H. Identification of a food pattern characterized by high-fibre and low-fat food choices associated with low prospective weight change in the EPIC-Potsdam cohort. J. Nutr. 2005, 135, 1183–1189. [CrossRef] [PubMed]
25. Davis, J.N.; Alexander, K.E.; Ventura, E.E.; Toledo-Corral, C.M.; Goran, M.I. Inverse relation between dietary fibre intake and visceral adiposity in overweight Latino youth. Am. J. Clin. Nutr. 2009, 90, 1160–1166. [CrossRef] [PubMed]
26. Du, H.; van der A, D. L.; Boshuizen, H.C.; Forouhi, N.G.; Wareham, N.J.; Halkjær, J.; Tjønneland, A.; Overvad, K.; Jakobsen, M.U.; Boeing, H.; et al. Dietary fibre and subsequent changes in body weight and waist circumference in European men and women. Am. J. Clin. Nutr. 2010, 91, 329–336. [CrossRef] [PubMed]
27. Koh-Banerjee, P.; Chu, N.F.; Spiegelman, D.M.; Rosner, B.; Colditz, G.; Willett, W.; Rimm, E. Prospective study of the association of changes in dietary intake, physical activity, alcohol consumption, and smoking with 9-y gain in waist circumference among 16,587 US men. Am. J. Clin. Nutr. 2003, 78, 719–727. [CrossRef] [PubMed]
28. Pol, K.; Christensen, R.; Bartels, E.M.; Raben, A.; Tetens, I.; Kristensen, M. Whole grain and body weight changes in apparently healthy adults: A systematic review and meta-analysis of randomized controlled studies. Am. J. Clin. Nutr. 2013, 98, 872–884. [CrossRef] [PubMed]
29. Kim, S.J.; de Souza, R.J.; Choo, V.L.; Ha, V.; Cozma, A.I.; Chiavaroli, L.; Mirrahimi, A.; Blanco Mejia, S.; Di Buono, M.; Bernstein, A.M.; et al. Effects of dietary pulse consumption on body weight: A systematic review and meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2016, 103, 1213–1223. [CrossRef] [PubMed]
30. Mytton, O.T.; Nnoaham, K.; Eyles, H.; Scarborough, P.; Mhurchu, C.N. Systematic review and meta-analysis of the effect of increased vegetable and fruit consumption on body weight and energy intake. BMC Public Health 2014, 14, 886–897. [CrossRef] [PubMed]
31. Thompson, S.V.; Hannon, B.A.; An, R.; Holscher, H.D. Effects of isolated soluble fibre supplementation on body weight, glycemia, and insulinemia in adults with overweight and obesity: A systematic review and meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2017, 106, 1514–1528. [CrossRef] [PubMed]
32. McRae, M.P. Health Benefits of Dietary Whole Grain: An Umbrella Review of Meta-analyses. J. Chiropr. Med. 2017, 16, 10–18. [CrossRef] [PubMed]
33. Kirwan, J.P.; Malin, S.K.; Scelsi, A.R.; Kullman, E.L.; Navaneethan, S.D.; Pagadala, M.R.; Haus, J.M.; Filion, J.; Godin, J.P.; Kochhar, S.; et al. A Whole-Grain Diet reduces Cardiovascular Risk Factors in Overweight and Obese Adults: A Randomized Controlled Trial. J. Nutr. 2016, 146, 2244–2251. [CrossRef] [PubMed]
34. Papathanasopoulos, A.; Camilleri, M. Dietary Fibre Supplements: Effects in Obesity and Metabolic Syndrome and Relationship to Gastrointestinal Functions. Gastroenterology 2010, 138, 65–72. [CrossRef] [PubMed]
35. Karl, J.P.; Saltzman, E. The Role of Whole Grains in Body Weight Regulation. Adv. Nutr. 2012, 3, 697–707. [CrossRef] [PubMed]
36. Sanchez, D.; Miguel, M.; Aleixandre, A. Dietary fibre, gut peptides, and adipocytokines. J. Med. Food 2012, 15, 223–230. [CrossRef] [PubMed]
37. Costabile, G.; Griffo, E.; Cipriano, P.; Vetrani, C.; Vitale, M.; Mamone, G.; Rivellese, AA.; Riccardi, G.; Giacco, R. Subjective satiety and plasma PYY concentration after wholemeal pasta. Appetite 2018, 125, 172–181. [CrossRef] [PubMed]
38. Williams, B.A.; Grant, L.J.; Gidley, M.J.; Mikkelsen, D. Gut Fermentation of Dietary Fibres: Physico-Chemistry of Plant Cell Walls and Implications for Health. Int. J. Mol. Sci. 2017, 18, 2203. [CrossRef] [PubMed]
39. Dahiya, D.K.; Puniya, M.; Shandilya, U.K.; Dhewa, T.; Kumar, N.; Kumar, S.; Puniya, A.K.; Shukla, P. Gut Microbiota Modulation and Its Relationship with Obesity Using Prebiotic Fibres and Probiotics: A Review. Front. Microbiol. 2017, 8, 563. [CrossRef] [PubMed]
40. Sleeth, M.L.; Thompson, E.L.; Ford, H.E.; Zac-Varghese, S.E.; Frost, G. Free fatty acid receptor 2 and nutrient sensing: A proposed role for fibre, fermentable carbohydrates and short-chain fatty acids in appetite regulation. Nutr. Res. Rev. 2010, 23, 135–145. [CrossRef] [PubMed]
41. Kasubuchi, M.; Hasegawa, S.; Hiramatsu, T.; Ichimura, A.; Kimura, I. Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Forum Nutr. 2015, 7, 2839–2849. [CrossRef] [PubMed]
42. Giacco, R.; Della Pepa, G.; Luongo, D.; Riccardi, G. Whole grain intake in relation to body weight: From epidemiological evidence to clinical trials. Nutr. Metab. Cardiovasc. Dis. 2011, 21, 901–908. [CrossRef] [PubMed]
43. Parkar, S.G.; Stevenson, D.E.; Skinner, M.A. The potential influence of fruit polyphenols on colonic microflora and human gut health. Int. J. Food Microbiol. 2008, 124, 295–298. [CrossRef] [PubMed]
44. Simpson, H.L.; Campbell, B.J. Review article: Dietary fibre-microbiota interactions. Aliment. Pharmacol. Ther. 2015, 42, 158–179. [CrossRef] [PubMed]
45. Liese, A.D.; Roach, A.K.; Sparks, K.C.; Marquart, L.; D’Agostino, R.B., Jr.; Mayer-Davis, E.J. Whole-grain intake and insulin sensitivity: The Insulin Resistance Atherosclerosis Study. Am. J. Clin. Nutr. 2003, 78, 965–971. [CrossRef] [PubMed]
46. Pereira, M.A.; Jacobs, D.R., Jr.; Pins, J.J.; Raatz, S.K.; Gross, M.D.; Slavin, J.L.; Seaquist, E.R. Effect of whole grains on insulin sensitivity in overweight hyperinsulinemic adults. Am. J. Clin. Nutr. 2002, 75, 848–855. [CrossRef] [PubMed]
47. Juntunen, K.S.; Laaksonen, D.E.; Poutanen, K.S.; Niskanen, L.K.; Mykkänen, H.M. High fiber rye bread and insulin secretion and sensitivity in healthy postmenopausal women. Am. J. Clin. Nutr. 2003, 77, 385–391. [CrossRef] [PubMed]
48. McIntosh, G.H.; Noakes, M.; Royle, P.J.; Foster, P.R. Whole grain rye and wheat foods and markers of bowel health in overweight middle aged men. Am. J. Clin. Nutr. 2003, 77, 967–974. [CrossRef] [PubMed]
49. Andersson, A.; Tengblad, S.; Karlström, B.; Kamal Eldin, A.; Landberg, R.; Basu, S.; Aman, P.; Vessby, B. Whole grain foods do not affect insulin sensitivity or markers of lipid peroxidation and inflammation in healthy, moderately overweight subjects. J. Nutr. 2007, 137, 1401–1407. [CrossRef] [PubMed]
50. Katcher, H.I.; Legro, R.S.; Kunselman, A.R.; Gillies, P.J.; Demers, L.M.; Bagshaw, D.M.; Kris-Etherton, P.M. The effects of a whole grain enriched hypocaloric diet on cardiovascular disease risk factors in men and women with metabolic syndrome. Am. J. Clin. Nutr. 2008, 87, 79–90. [CrossRef] [PubMed]
51. Giacco, R.; Clemente, G.; Cipriano, D.; Luongo, D.; Viscovo, D.; Patti, L.; Di Marino, L.; Giacco, A.; Naviglio, D.; Bianchi, M.A.; et al. Effects of the regular consumption of wholemeal wheat foods on cardiovascular risk factors in healthy people. Nutr. Metab. Cardiovasc. Dis. 2010, 20, 186–194. [CrossRef] [PubMed]
52. Brownlee, I.A.; Moore, C.; Chatfield, M.; Richardson, D.P.; Ashby, P.; Kuznesof, S.A.; Jebb, S.A.; Seal, C.J. Markers of cardiovascular risk are not changed by increased whole grain intake: The WHOLEheart study, a randomised, controlled dietary intervention. Br. J. Nutr. 2010, 104, 125–134. [CrossRef] [PubMed]
53. Giacco, R.; Lappi, J.; Costabile, G.; Kolehmainen, M.; Schwab, U.; Landberg, R.; Uusitupa, M.; Poutanen, K.; Pacini, G.; Rivellese, A.A.; et al. Effects of rye and whole wheat versus refined cereal foods on metabolic risk factors: A randomised controlled two-centre intervention study. Clin. Nutr. 2013, 32, 941–949. [CrossRef] [PubMed]
54. Giacco, R.; Costabile, G.; Della Pepa, G.; Anniballi, G.; Griffo, E.; Mangione, A.; Cipriano, P.; Viscovo, D.; Clemente, G.; Landberg, R.; et al. A whole-grain cereal-based diet lowers postprandial plasma insulin and triglyceride levels in individuals with metabolic syndrome. Nutr. Metab. Cardiovasc. Dis. 2014, 24, 837–844. [CrossRef] [PubMed]
55. He, L.X.; Zhao, J.; Huang, Y.S.; Li, Y. The difference between oats and beta-glucan extract intake in the management of HbA1c, fasting glucose and insulin sensitivity: A meta-analysis of randomized controlled trials. Food Funct. 2016, 7, 1413–1428. [CrossRef] [PubMed]
56. Hashizume, C.; Kishimoto, Y.; Kanahori, S.; Yamamoto, T.; Okuma, K.; Yamamoto, K. Improvement effect of resistant maltodextrin in humans with metabolic syndrome by continuous administration. J. Nutr. Sci. Vitaminol. 2012, 58, 423–430. [CrossRef] [PubMed]
57. Li, S.; Guerin-Deremaux, L.; Pochat, M.; Wils, D.; Reifer, C.; Miller, L.E. NUTRIOSE dietary fiber supplementation improves insulin resistance and determinants of metabolic syndrome in overweight men: A double-blind, randomized, placebo-controlled study. Appl. Physiol. Nutr. MeTable 2010, 35, 773–782. [CrossRef] [PubMed]
58. Johnston, K.L.; Thomas, E.L.; Bell, J.D.; Frost, G.S.; Robertson, M.D. Resistant starch improves insulin sensitivity in metabolic syndrome. Diabet. Med. 2010, 27, 391–397. [CrossRef] [PubMed]
59. Robertson, M.D.; Wright, J.W.; Loizon, E.; Debard, C.; Vidal, H.; Shojaee-Moradie, F.; Russell-Jones, D.; Umpleby, A.M. Insulin-sensitizing effects on muscle and adipose tissue after dietary fiber intake in men and women with metabolic syndrome. J. Clin. Endocrinol. MeTable 2012, 97, 3326–3332. [CrossRef] [PubMed]
60. Layden, B.T.; Yalamanchi, S.K.; Wolever, T.M.; Dunaif, A.; Lowe, W.L., Jr. Negative association of acetate with visceral adipose tissue and insulin levels. Diabetes Metab. Syndr. Obes. 2012, 5, 49–55. [CrossRef] [PubMed]
61. Canfora, E.E.; Jocken, J.W.; Blaak, E.E. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat. Rev. Endocrinol. 2015, 11, 577–591. [CrossRef] [PubMed]
62. Vetrani, C.; Costabile, G.; Luongo, D.; Naviglio, D.; Rivellese, A.A.; Riccardi, G.; Giacco, R. Effects of whole-grain cereal foods on plasma short chain fatty acid concentrations in individuals with the metabolic syndrome. Nutrition 2016, 32, 217–221. [CrossRef] [PubMed]
63. Weitkunat, K.; Stuhlmann, C.; Postel, A.; Rumberger, S.; Fankhänel, M.; Woting, A.; Petzke, K.J.; Gohlke, S.; Schulz, T.J.; Blaut, M.; et al. Short-chain fatty acids and inulin, but not guar gum, prevent diet-induced obesity and insulin resistance through differential mechanisms in mice. Sci Rep. 2017, 7, 6109. [CrossRef] [PubMed]
64. Harris, K.; Kassis, A.; Major, G.; Chou, C.J. Is the gut microbiota a new factor contributing to obesity and its metabolic disorders? J. Obes. 2012, 2012, 879151. [PubMed]
65. Caricilli, A.M.; Saad, M.J. The role of gut microbiota on insulin resistance. Nutrients 2013, 5, 829–851. [CrossRef] [PubMed]
66. Da Silva, S.T.; dos Santos, C.A.; Bressan, J. Intestinal microbiota; relevance to obesity and modulation by prebiotics and probiotics. Nutr. Hosp. 2013, 28, 1039–1048. [PubMed]
67. Cameron-Smith, D.; Habito, R.; Barnett, M.; Collier, G.R. Dietary guar gum improves insulin sensitivity in streptozotocin-induced diabetic rats. J. Nutr. 1997, 127, 359–364. [CrossRef] [PubMed]
68. Song, Y.J.; Sawamura, M.; Ikeda, K.; Igawa, S.; Yamori, Y. Soluble dietary fibre improves insulin sensitivity by increasing muscle GLUT-4 content in stroke-prone spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 2000, 27, 41–45. [CrossRef] [PubMed]
69. Salmerón, J.; Manson, J.E.; Stampfer, M.J.; Colditz, G.A.; Wing, A.L.; Willett, W.C. Dietary fibre, glycaemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 1997, 277, 472–477. [CrossRef] [PubMed]
70. The InterAct Consortium. Dietary fibre and incidence of type 2 diabetes in eight European countries: The EPIC-InterAct study and a meta-analysis of prospective studies. Diabetologia 2015, 58, 1394–1408.
71. King, D.E.; Mainous, A.G.; Lambourne, C.A. Trends in dietary fibre intake in the United States, 1999–2008. J. Acad. Nutr. Diet. 2012, 112, 642–648. [CrossRef] [PubMed]
72. McGill, C.R.; Fulgoni, V.L.; Devareddy, L. Ten-year trends in fibre and whole grain intakes and food sources for the United States population: National health and nutrition examination survey 2001–2010. Nutrients 2015, 7, 1119–1130. [CrossRef] [PubMed]
73. Fungwe, T.V.; Bente, L.; Hiza, H. Food Supply and Dietary Fibre: Its Availability and Effect on Health; Nutrition Insights 36; USDA Center for Nutrition Policy and Promotion: Alexandria, VA, USA, 2007.
74. Lindström, J.; Peltonen, M.; Eriksson, J.G.; Louheranta, A.; Fogelholm, M.; Uusitupa, M.; Tuomilehto, J. High-fibre, low-fat diet predicts long-term weight loss and decreased type 2 diabetes risk: The Finnish Diabetes Prevention Study. Diabetologia 2006, 49, 912–920. [CrossRef] [PubMed]
75. Von Ruesten, A.; Feller, S.; Bergmann, M.M.; Boeing, H. Diet and risk of chronic diseases: Results from the first 8 years of follow-up in the EPIC-Potsdam study. Eur. J. Clin. Nutr. 2013, 67, 412–419. [CrossRef] [PubMed]
76. InterAct, Consortium; Romaguera, D.; Guevara, M.; Norat, T.; Langenberg, C.; Forouhi, N.G.; Sharp, S.; Slimani, N.; Schulze, M.B.; Buijsse, B.; et al. Mediterranean diet and type 2 diabetes risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study: The InterAct project. Diabetes Care 2011, 34, 1913–1918.
77. Martinez-Gonzalez, M.A.; Salas-Salvado, J.; Estruch, R.; Corella, D.; Fito, M.; Ros, E. Benefits of the Mediterranean diet: Insights from the PREDIMED study. Prog. Cardiovasc. Dis. 2015, 58, 50–60. [CrossRef] [PubMed]
78. Vitale, M.; Masulli, M.; Rivellese, A.A.; Babini, A.C.; Boemi, M.; Bonora, E.; Buzzetti, R.; Ciano, O.; Cignarelli, M.; Cigolini, M.; et al. Influence of dietary fat and carbohydrates proportions on plasma lipids, glucose control and low grade inflammation in patients with type 2 diabetes—The TOSCA.IT Study. Eur. J. Nutr. 2016, 55, 1645–1651. [CrossRef] [PubMed]
79. Post, R.E.; Mainous, A.G.; King, D.E.; Simpson, K.N. Dietary fibre for the treatment of type 2 diabetes mellitus: A meta-analysis. J. Am. Board Fam. Med. 2012, 25, 16–23. [CrossRef] [PubMed]
80. Silva, F.M.; Kramer, C.K.; de Almeida, J.C.; Steemburgo, T.; Gross, J.L.; Azevedo, M.J. Fiber intake and glycemic control in patients with type 2 diabetes mellitus: A systematic review with meta-analysis of randomized controlled trials. Nutr. Rev. 2013, 71, 790–801. [CrossRef] [PubMed]
81. Gibb, R.D.; McRorie, J.W., Jr.; Russell, D.A.; Hasselblad, V.; D’Alessio, D.A. Psyllium fiber improves glycemic control proportional to loss of glycemic control: A meta-analysis of data in euglycemic subjects, patients at risk of type 2 diabetes mellitus, and patients being treated for type 2 diabetes mellitus. Am. J. Clin. Nutr. 2015, 102, 1604–1614. [CrossRef] [PubMed]
82. Schwingshackl, L.; Chaimani, A.; Hoffmann, G.; Schwedhelm, C.; Boeing, H. A network meta-analysis on the comparative efficacy of different dietary approaches on glycaemic control in patients with type 2 diabetes mellitus. Eur. J. Epidemiol. 2018. [CrossRef] [PubMed]
83. Marventano, S.; Vetrani, C.; Vitale, M.; Godos, J.; Riccardi, G.; Grosso, G. Whole Grain Intake and Glycaemic Control in Healthy Subjects: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients 2017, 19, 9. [CrossRef] [PubMed]
84. Christensen, A.S.; Viggers, L.; Hasselström, K.; Gregersen, S. Effect of fruit restriction on glycemic control in patients with type 2 diabetes—A randomized trial. Nutr. J. 2013, 12, 29. [CrossRef] [PubMed]
85. Muraki, I.; Imamura, F.; Manson, J.E.; Hu, F.B.; Willett, W.C.; van Dam, R.M.; Sun, Q. Fruit consumption and risk of type 2 diabetes: Results from three prospective longitudinal cohort studies. BMJ 2013, 347, f5001. [CrossRef] [PubMed]
86. Bozzetto, L.; Alderisio, A.; Giorgini, M.; Barone, F.; Giacco, A.; Riccardi, G.; Rivellese, A.A.; Annuzzi, G. Extra-Virgin Olive Oil Reduces Glycemic Response to a High-Glycemic Index Meal in Patients With Type 1 Diabetes: A Randomized Controlled Trial. Diabetes Care 2016, 39, 518–524. [CrossRef] [PubMed]
87. Wu, K.; Bowman, R.; Welch, A.A.; Luben, R.N.; Wareham, N.; Khaw, K.-T.; Bingham, S.A. Apolipoprotein E polymorphisms, dietary fat and fibre, and serum lipids: The EPIC Norfolk study. Eur. Heart J. 2007, 28, 2930–2936. [CrossRef] [PubMed]
88. Vitale, M.; Masulli, M.; Cocozza, S.; Anichini, R.; Babini, A.C.; Boemi, M.; Bonora, E.; Buzzetti, R.; Carpinteri, R.; Caselli, C.; et al. Sex differences in food choices, adherence to dietary recommendations and plasma lipid profile in type 2 diabetes e The TOSCA.IT study. Nutr. Metab. Cardiovasc. Dis. 2016, 26, 879–885. [CrossRef] [PubMed]
89. Ye, E.; Chacko, S.; Chou, E.; Kugizaki, M.; Liu, S. Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J. Nutr. 2012, 142, 1304–1313. [CrossRef] [PubMed]
90. Hollander, P.; Ross, A.; Kristensen, M. Whole-grain and blood lipid changes in apparently healthy adults: A systematic review and meta-analysis of randomized controlled studies. Am. J. Clin. Nutr. 2015, 102, 556–572. [CrossRef] [PubMed]
91. Hartley, L.; May, M.D.; Loveman, E.; Colquitt, J.L.; Rees, K. Dietary fibre for the primary prevention of cardiovascular disease. Cochrane Database Syst. Rev. 2016. [CrossRef] [PubMed]
92. Kelly, S.A.; Hartley, L.; Loveman, E.; Colquitt, J.L.; Jones, H.M.; Al-Khudairy, L.; Clar, C.; Germanò, R.; Lunn, H.R.; Frost, G.; et al. Whole grain cereals for the primary or secondary prevention of cardiovascular disease. Cochrane Database Syst. Rev. 2017, 8. [CrossRef] [PubMed]
93. Whitehead, A.; Beck, E.J.; Tosh, S.; Wolever, T.M.S. Cholesterol-lowering effects of oat β-glucan: A meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2014, 100, 1413–1421. [CrossRef] [PubMed]
94. Zhu, X.; Sun, X.; Wang, M.; Zhang, C.; Cao, Y.; Mo, G.; Liang, J.; Zhu, S. Quantitative assessment of the effects of β-glucan consumption on serum lipid profile and glucose level in hypercholesterolemic subjects. Nutr. Metab. Cardiovasc. Dis. 2015, 25, 714–723. [CrossRef] [PubMed]
95. Ho, H.V.; Sievenpiper, J.L.; Zurbau, A.; Blanco Mejia, S.; Jovanovski, E.; Au-Yeung, F.; Jenkins, A.L.; Vuksan, V. A systematic review and meta-analysis of randomized controlled trials of the effect of barley β-glucan on LDL-C, non-HDL-C and apoB for cardiovascular disease risk reduction. Eur. J. Clin. Nutr. 2016, 70, 1239–1245. [CrossRef] [PubMed]
96. Ho, H.V.T.; Sievenpiper, J.L.; Zurbau, A.; Blanco Mejia, S.; Jovanovski, E.; Au-Yeung, F.; Jenkins, A.L.; Vuksan, V. The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: A systematic review and meta-analysis of randomised-controlled trials. Br. J. Nutr. 2016, 116, 1369–1382. [CrossRef] [PubMed]
97. Bazzano, L.; Thompson, A.; Tees, M.; Nguyen, C.; Winham, D. Non-Soy Legume Consumption Lowers Cholesterol Levels: A Meta-Analysis of Randomized Controlled Trials. Nutr. Metab. Cardiovasc. Dis. 2011, 21, 94–103. [CrossRef] [PubMed]
98. Bernstein, A.M.; Titgemeier, B.; Kirkpatrick, K.; Golubic, M.; Roizen, M.F. Major Cereal Grain Fibres and Psyllium in Relation to Cardiovascular Health. Nutrients 2013, 5, 1471–1487. [CrossRef] [PubMed]
99. Ha, V.; Sievenpiper, J.L.; de Souza, R.J.; Jayalath, V.H.; Mirrahimi, A.; Agarwal, A.; Chiavaroli, L.; Blanco Mejia, S.; Sacks, F.M.; Di Buono, M.; et al. Effect of dietary pulse intake on established therapeutic lipid targets for cardiovascular risk reduction: A systematic review and meta-analysis of randomized controlled trials. CMAJ 2014, 186, 252–262. [CrossRef] [PubMed]
100. Pirro, M.; Vetrani, C.; Bianchi, C.; Mannarino, M.R.; Bernini, F.; Rivellese, A.A. Joint position statement on “Nutraceuticals for the treatment of hypercholesterolemia” of the Italian Society of Diabetology (SID) and of the Italian Society for the Study of Arteriosclerosis (SISA). Nutr. Metab. Cardiovasc. Dis. 2017, 27, 2–17. [CrossRef] [PubMed]
101. Liu, F.; Prabhakar, M.; Ju, J.; Long, H.; Zhou, H.W. Effect of inulin-type fructans on blood lipid profile and glucose level: A systematic review and meta-analysis of randomized controlled trials. Eur. J. Clin. Nutr. 2017, 71, 9–20. [CrossRef] [PubMed]
102. De Natale, C.; Annuzzi, G.; Bozzetto, L.; Mazzarella, R.; Costabile, G.; Ciano, O.; Riccardi, G.; Rivellese, A.A. Effects of a Plant-Based High-Carbohydrate/High-Fibre Diet Versus High-Monounsaturated Fat/Low-Carbohydrate Diet on Postprandial Lipids in Type 2 Diabetic Patients. Diabetes Care 2009, 32, 2168–2173. [CrossRef] [PubMed]
103. Bozzetto, L.; De Natale, C.; Di Capua, L.; Della Corte, G.; Patti, L.; Maione, S.; Riccardi, G.; Rivellese, A.A.; Annuzzi, G. The association of hs-CRP with fasting and postprandial plasma lipids in patients with type 2 diabetes is disrupted by dietary monounsaturated fatty acids. Acta Diabetol. 2013, 50, 273–276. [CrossRef] [PubMed]
104. Bozzetto, L.; Annuzzi, G.; Costabile, G.; Costagliola, L.; Giorgini, M.; Alderisio, A.; Strazzullo, A.; Patti, L.; Cipriano, P.; Mangione, A.; et al. A CHO/fibre diet reduces and a MUFA diet increases postprandial lipaemia in type 2 diabetes: No supplementary effects of low-volume physical training. Acta Diabetol. 2014, 51, 385–393. [CrossRef] [PubMed]
105. Othman, R.A.; Moghadasian, M.H.; Jones, P.J. Cholesterol-lowering effects of oat β-glucan. Nutr. Rev. 2011, 69, 299–309. [CrossRef] [PubMed]
106. Bozzetto, L.; Annuzzi, G.; Corte, G.D.; Patti, L.; Cipriano, P.; Mangione, A.; Riccardi, G.; Rivellese, A.A. Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes. Atherosclerosis 2011, 217, 142–148. [CrossRef] [PubMed]
107. Lamarche, B.; Desroches, S.; Jenkins, D.J.; Kendall, C.W.; Marchie, A.; Faulkner, D.; Vidgen, E.; Lapsley, K.G.; Trautwein, E.A.; Parker, T.L.; et al. Combined effects of a dietary portfolio of plant sterols, vegetable protein, viscous fibre and almonds on LDL particle size. Br. J. Nutr. 2004, 92, 657–663. [CrossRef] [PubMed]
108. Lairon, D.; Play, B.; Jourdheuil-Rahmani, D. Digestible and indigestible carbohydrates: Interactions with postprandial lipid metabolism. J. Nutr. Biochem. 2007, 18, 217–227. [CrossRef] [PubMed]
109. Lim, S.S.; Vos, T.; Flaxman, A.D.; Danaei, G.; Shibuya, K.; Adair-Rohani, H.; Amann, M.; Anderson, H.R.; Andrews, K.G.; Aryee, M.; et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380, 2224–2260. [CrossRef]
110. Vernay, M.; Aïdara, M.; Salanave, B.; Deschamps, V.; Malon, A.; Oleko, A.; Mallion, J.M.; Hercberg, S.; Castetbon, K. Diet and blood pressure in 18–74-year-old adults: The French Nutrition and Health Survey (ENNS, 2006–2007). J. Hypertens. 2012, 30, 1920–1927. [CrossRef] [PubMed]
111. Gopinath, B.; Flood, V.M.; Rochtchina, E.; Baur, L.A.; Smith, W.; Mitchell, P. Influence of High Glycemic Index and Glycemic Load Diets on Blood Pressure During Adolescence. Hypertension 2012, 59, 1272–1277. [CrossRef] [PubMed]
112. Aljuraiban, G.S.; Griep, L.M.O.; Chan, Q.; Daviglus, M.L.; Stamler, J.; Van Horn, L.; Elliott, P.; Frost, G.S. Total, insoluble and soluble dietary fibre intake in relation to blood pressure: The INTERMAP Study. Br. J. Nutr. 2015, 114, 1480–1486. [CrossRef] [PubMed]
113. Lairon, D.; Arnault, N.; Bertrais, S.; Planells, R.; Clero, E.; Hercberg, S.; Boutron-Ruault, M.C. Dietary fiber intake and risk factors for cardiovascular disease in French adults. Am. J. Clin. Nutr. 2005, 82, 1185–1194. [CrossRef] [PubMed]
114. Wang, L.; Gaziano, J.M.; Liu, S.; Manson, J.E.; Buring, J.E.; Sesso, H.D. Whole-and refined-grain intakes and the risk of hypertension in women. Am. J. Clin. Nutr. 2007, 86, 472–479. [CrossRef] [PubMed]
115. Streppel, M.T.; Arends, L.R.; Van’t Veer, P.; Grobbee, D.E.; Geleijnse, J.M. Dietary fiber and blood pressure: A meta-analysis of randomized placebo-controlled trials. Arch. Intern. Med. 2005, 165, 150–156. [CrossRef] [PubMed]
116. Whelton, S.P.; Hyre, A.D.; Pedersen, B.; Yi, Y.; Whelton, P.K.; He, J. Effect of dietary fiber intake on blood pressure: A meta-analysis of randomized, controlled clinical trials. J. Hypertens. 2005, 23, 475–481. [CrossRef] [PubMed]
117. Evans, C.E.L.; Greenwood, D.C.; Threapleton, D.E.; Cleghorn, C.L.; Nykjaer, C.; Woodhead, C.E.; Gale, C.P.; Burley, V.J. Effects of dietary fibre type on blood pressure: A systematic review and meta-analysis of randomized controlled trials of healthy individuals. J. Hypertens. 2015, 33, 897–911. [CrossRef] [PubMed]
118. Khan, K.; Jovanovski, E.; Ho, H.V.T.; Marques, A.C.R.; Zurbau, A.; Mejia, S.B.; Sievenpiper, J.L.; Vuksan, V. The effect of viscous soluble fiber on blood pressure: A systematic review and meta-analysis of randomized controlled trials. Nutr. Metab. Cardiovasc. Dis. 2018, 28, 3–13. [CrossRef] [PubMed]
119. Schulman, I.H.; Zhou, M.S. Vascular insulin resistance: A potential link between cardiovascular and metabolic diseases. Curr. Hypertens. Rep. 2009, 11, 48–55. [CrossRef] [PubMed]
120. Zhou, M.S.; Schulman, I.H.; Raij, L. Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: Role of nuclear factor kappa B activation. J. Hypertens. 2010, 28, 527–535. [CrossRef] [PubMed]
121. Nickenig, G.; Sachinidis, A.; Michaelsen, F.; Bohm, M.; Seewald, S.; Vetter, H. Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells. Circulation 1997, 95, 473–478. [CrossRef] [PubMed]
122. Haas, J.T.; Francque, S.; Stael, B. Pathophysiology and mechanisms of nonalcoholic fatty liver disease. Annu. Rev. Physiol. 2016, 78, 181–205. [CrossRef] [PubMed]
123. Della Pepa, G.; Vetrani, C.; Lombardi, G.; Bozzetto, L.; Annuzzi, G.; Rivellese, A.A. Isocaloric dietary changes and non-alcoholic fatty liver disease in high cardiometabolic risk individuals. Nutrients 2017, 9, 1065. [CrossRef] [PubMed]
124. Cortez-Pinto, H.; Jesus, L.; Barros, H.; Lopes, C.; Moura, M.C.; Camilo, M.E. How different is the dietary pattern in non-alcoholic steatohepatitis patients? Clin. Nutr. 2006, 25, 816–823. [CrossRef] [PubMed]
125. Musso, G.; Gambino, R.; De Michieli, F.; Cassader, M.; Rizzetto, M.; Durazzo, M.; Faga, E.; Silli, B.; Pagano, G. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 2003, 37, 909–916. [CrossRef] [PubMed]
126. Mirmiran, P.; Amirhamidi, Z.; Ejtahed, H.S.; Bahadoran, Z.; Azizi, F. Relationship between Diet and Non-alcoholic Fatty Liver Disease: A Review Article. Iran J. Public Health 2017, 46, 1007–1017. [PubMed]
127. Razavi Zade, M.; Telkabadi, M.H.; Bahmani, F.; Salehi, B.; Farshbaf, S.; Asemi, Z. The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: A randomized clinical trial. Liver Int. 2016, 36, 563–571. [CrossRef] [PubMed]
128. Zelber-Sagi, S.; Salomone, F.; Mlynarsky, L. The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms. Liver Int. 2017, 37, 936–949. [CrossRef] [PubMed]
129. Bozzetto, L.; Prinster, A.; Annuzzi, G.; Costagliola, L.; Mangione, A.; Vitelli, A.; Mazzarella, R.; Longobardo, M.; Mancini, M.; Vigorito, C.; et al. Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients. Diabetes Care 2012, 35, 1429–1435. [CrossRef] [PubMed]
130. Daubioul, C.A.; Horsmans, Y.; Lambert, P.; Danse, E.; Delzenne, N.M. Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: Results of a pilot study. Eur. J. Clin. Nutr. 2005, 59, 723–726. [CrossRef] [PubMed]
131. Barrera, F.; George, J. The role of diet and nutritional intervention for the management of patients with NAFLD. Clin. Liver Dis. 2014, 18, 91–112. [CrossRef] [PubMed]
132. Parnell, J.A.; Reimer, A.R. Prebiotic fiber modulation of the gut microbiota improves risk factors for obesity and the metabolic syndrome. Gut Microbes 2012, 3, 29–34. [CrossRef] [PubMed]
133. Bozzetto, L.; Annuzzi, G.; Ragucci, M.; Di Donato, O.; Della Pepa, G.; Della Corte, G.; Griffo, E.; Anniballi, G.; Giacco, A.; Mancini, M.; et al. Insulin resistance, postprandial GLP-1 and adaptive immunity are the main predictors of NAFLD in a homogeneous population at high cardiovascular risk. Nutr. Metab. Cardiovasc. Dis. 2016, 26, 623–629. [CrossRef] [PubMed]
134. Threapleton, D.E.; Greenwood, D.C.; Evans, C.E.; Cleghorn, C.L.; Nykjaer, C.; Woodhead, C.; Cade, J.E.; Gale, C.P.; Burley, V.J. Dietary fibre intake and risk of cardiovascular disease: Systematic review and meta-analysis. BMJ 2013, 347, f6879. [CrossRef] [PubMed]
135. Wu, Y.; Qian, Y.; Pan, Y.; Li, P.; Yang, J.; Ye, X.; Xu, G. Association between dietary fibre intake and risk of coronary heart disease: A meta-analysis. Clin. Nutr. 2015, 34, 603–611. [CrossRef] [PubMed]
136. Ning, H.; Van Horn, L.; Shay, C.M.; Lloyd-Jones, D.M. Associations of dietary fibre intake with long-term predicted cardiovascular disease risk and C-reactive protein levels (from the National Health and Nutrition Examination Survey Data [2005–2010]). Am. J. Cardiol. 2014, 113, 287–291. [CrossRef] [PubMed]
137. Buil-Cosiales, P.; Zazpe, I.; Toledo, E.; Corella, D.; Salas-Salvadó, J.; Diez-Espino, J.; Ros, E.; Fernandez-Creuet Navajas, J.; Santos-Lozano, J.M.; Arós, F.; et al. Fibre intake and all-cause mortality in the Prevención con Dieta Mediterránea (PREDIMED) study. Am. J. Clin. Nutr. 2014, 100, 1498–1507. [CrossRef] [PubMed]
138. Kim, Y.; Je, Y. Dietary fibre intake and mortality from cardiovascular disease and all cancers: A meta-analysis of prospective cohort studies. Arch. Cardiovasc. Dis. 2016, 109, 39–54. [CrossRef] [PubMed]
139. Estruch, R.; Ros, E.; Salas-Salvadó, J.; Covas, M.I.; Corella, D.; Arós, F.; Gómez-Gracia, E.; Ruiz-Gutiérrez, V.; Fiol, M.; Lapetra, J.; et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N. Engl. J. Med. 2013, 368, 1279–1290. [CrossRef] [PubMed]